We are live on
!
Find out more
ZAM
Zevin Asset Management Portfolio holdings
AUM
$723M
1-Year Est. Return
15.62%
This Fund
S&P 500
This Quarter
Est. Return
+8.41%
1 Year Est. Return
+15.62%
3 Year Est. Return
+57.49%
5 Year Est. Return
+80.59%
10 Year Est. Return
+296.42%
AUM
$460M
AUM Growth
+$37.1M
(+8.8%)
Cap. Flow
+$2.02M
Cap. Flow
% of AUM
0.44%
Top 10 Holdings %
Top 10 Hldgs %
39.32%
Holding
83
New
7
Increased
23
Reduced
28
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$6.56M |
| 2 |
PNC Financial Services
PNC
|
+$741K |
| 3 |
Amazon
AMZN
|
+$667K |
| 4 |
Colgate-Palmolive
CL
|
+$664K |
| 5 |
Kroger
KR
|
+$574K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$1.58M |
| 2 |
Automatic Data Processing
ADP
|
+$1.24M |
| 3 |
Apple
AAPL
|
+$1.13M |
| 4 |
Ulta Beauty
ULTA
|
+$956K |
| 5 |
Verizon
VZ
|
+$750K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.62% |
| 2 | Financials | 14.7% |
| 3 | Consumer Discretionary | 14.56% |
| 4 | Consumer Staples | 12.19% |
| 5 | Healthcare | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Berkshire Hathaway Class B
BRK.B
$1.1T
| $282K | 0.06% |
913
+60
| +7% | +$17.8K |
|
52
O'Reilly Automotive
ORLY
$73B
| $270K | 0.06% |
4,800
| – | – |
|
53
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.7B
| $247K | 0.05% |
4,100
| – | – |
|
54
Kimberly-Clark
KMB
$36.5B
| $237K | 0.05% |
+1,746
| New | +$222K |
|
55
General Mills
GIS
$19.1B
| $226K | 0.05% |
2,690
| – | – |
|
56
Coca-Cola
KO
$377B
| $219K | 0.05% |
+3,440
| New | +$208K |
|
57
Omnicom Group
OMC
$21.5B
| $212K | 0.05% |
+2,600
| New | +$193K |
|
58
Johnson & Johnson
JNJ
$622B
| $207K | 0.05% |
+1,174
| New | +$203K |
|
59
AllianceBernstein
AB
$3.43B
| $204K | 0.04% |
5,930
| – | – |
|
60
Artisan Partners
APAM
$2.78B
| $203K | 0.04% |
+6,830
| New | +$210K |
|
|
TEF
61
DELISTED
Telefonica
TEF
| $191K | 0.04% |
53,575
| – | – |
|
|
FLG
62
Flagstar Bank National Association
FLG
$5.96B
| $99K | 0.02% |
3,830
| – | – |
|
|
63
GSK
GSK
$104B
| – | – |
-53,806
| Closed | -$1.58M |
|
|
HBI
64
DELISTED
Hanesbrands
HBI
| – | – |
-13,760
| Closed | -$96K |
|
65
Haleon
HLN
$43.6B
| – | – |
-11,069
| Closed | -$67K |
|
Similar funds
PPW
VCM
FFM
AGAM
ZDA
FIS
TFHU
FAN
Zevin Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, Zevin Asset Management held 83 positions worth $460M, up 8.8% from $423M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Zevin Asset Management's Q4 2022 filing shows 7 new, 23 increased, 28 reduced and 6 closed positions. Its largest new stake was AstraZeneca: 52,344 shares worth $7.1M. The largest sale was GSK, an estimated $1.58M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
- Zevin Asset Management's largest Q4 2022 buy was AstraZeneca: 52,344 shares worth $7.1M.
- Zevin Asset Management added most to PNC Financial Services in Q4 2022, an estimated $741K increase.
- Zevin Asset Management's biggest Q4 2022 reduction was Automatic Data Processing, cutting an estimated $1.24M.
- Zevin Asset Management fully exited GSK in Q4 2022, selling an estimated $1.58M.
- Zevin Asset Management's ten largest holdings make up 39% of its $460M portfolio in Q4 2022.
- Zevin Asset Management opened 7 new positions and closed 6 in Q4 2022.
- Zevin Asset Management's portfolio value rose 8.8% quarter-over-quarter to $460M.
Based on Zevin Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.